Skip to main content
Caplight Logo









Inato

Inato

Private
ParisHealthcare & Life Scienceshttps://www.inato.com/

Last Round

Series A

Extension

Mar 29, 2023

Total Funding Raised

$35.52M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Inato is a health technology company that provides an AI-powered platform to connect pharmaceutical sponsors, research sites, and patients to improve the accessibility, inclusivity, and efficiency of clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Medical AI, Patient Engagement

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS

AI Layer

Application

Keywords

clinical trial marketplaceclinical trial platformpatient recruitmentsite selectionAI for clinical trialsClinTechpatient diversitycommunity research sitessite networkpatient enrollmentdecentralized clinical trialsDCTAI patient pre-screeningcontract research organizationCROoncology trialssite activationclinical trial design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inato Comparables

Compare Inato with similar companies based on industry and business-model similarity.

Inato comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elligo Health Research
77%
OneStudyTeam
75%
Paradigm Health
74%

Inato Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 29, 2023
Series AFeb 4, 2020
SeedNov 15, 2017

Key People

Founding team and executive leadership

Kourosh Davarpanah

Cofounder & CEO

Founding Team

Bastien Duret

Chief Technology Officer

Executive Team

Inato Investors

Notable investors and investment history

Inato investors
InvestorRounds
Kima VenturesSeed
Top Harvest CapitalSeries A Extension
Top Harvest CapitalSeries A Extension
Serena Data VenturesSeries A
Obvious VenturesSeries A Extension, Series A
Fly VenturesSeries A, Seed
La Maison PartnersSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Recognized on Fierce Healthcare’s Fierce 15 list.

  • Apr 1, 2026

    Platform now used by over 5,500 sites globally.

Inato Filings

Explore SEC and related filing metadata, where available.

Inato filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Inato's valuation, stock price, and market status.

Is Inato a public or private company?

Inato is a private company.

What is the current stock price of Inato?

Inato is a private company with no public stock price. No recent secondary market data is available.

How much is Inato worth (valuation)?

Valuation information for Inato is not publicly available.

Can I buy Inato stock?

Inato shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Inato's last funding round?

Inato's most recent funding round was Series A Extension on March 29, 2023.

Who are the main investors in Inato?

Key investors in Inato include Obvious Ventures, Cathay Innovation.

Will Inato IPO soon?

No public IPO plans have been announced for Inato.

How can I track Inato secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inato's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range73
Year Founded2016
Last FundingMar 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?